Sam M. Murray - Concepedia

Author

Sam M. Murray

Also Known As

Diana Munoz-Sandoval, James C. Moon, James Moon, S. Murray, Sam M. Murray, Sam M Murray, Sam M. Murray, Sam Murray, Vikas Kapil

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Imperial College London University of Oxford University of Birmingham University of Sheffield University College London

About

Sam M. Murray is an author at Imperial College London specializing in immunotherapy, immunology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	231
2	Immunology	2	2	231
3	Engineering	1	1	14
4	Pathology	1	1	14
5	Autoimmune Disease	1	1	14

Sam M. Murray

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Brian J. Willett, Joe Grove, Oscar A. MacLean, Nature Microbiology	2022	701
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection Catherine J. Reynolds, Leo Swadling, Joseph M. Gibbons, Science Immunology VaccinationImmunological MemoryMild Sars-cov-2 InfectionT Cell ResponsesUnited Kingdom Lockdown	2020	217
Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy. David J. Pinato, Sam M. Murray, Alejandro Forner, Journal for ImmunoTherapy of Cancer	2021	181
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease Eleanor Barnes, Carl S. Goodyear, Michelle Willicombe, Nature Medicine	2023	124
Examining the Immunological Effects of COVID-19 Vaccination in Patients with Conditions Potentially Leading to Diminished Immune Response Capacity – The OCTAVE Trial Pamela Kearns, Stefan Siebert, Michelle Willicombe, SSRN Electronic Journal	2021	74
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens Shona C. Moore, Barbara Kronsteiner, Stephanie Longet, Med	2023	46
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial Carl S. Goodyear, Amit K. Patel, Eleanor Barnes, The Lancet Rheumatology	2024	26
Impaired humoral and cellular response to primary <scp>COVID</scp>‐19 vaccination in patients less than 2 years after allogeneic bone marrow transplant Sam M. Murray, Maria Chiara Barbanti, Cori Campbell, British Journal of Haematology	2022	19
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients Sam M. Murray, Elisa Pose, Melanie Wittner, Journal of Hepatology	2023	16
Genetically engineered antibodies for diagnostic pathology Robert A. Spooner, Sam M. Murray, Gail Rowlinson‐Busza, Human Pathology Diagnostic PathologyEngineeringAutoimmune DiseaseMedicineImmunology	1994	14

Page 1